Weifeng Wang's Contact Details

Weifeng Wang's Company Details

至本医疗科技（上海）有限公司 OrigiMed

N/A, N/A, CN • 250 - 499 Employees
BioTech/Drugs

至本医疗科技（上海）有限公司 是一家科技转化型公司，专注于肿瘤分子生物学技术的研发及临床应用转化。致力于为每一位癌症患者提供全面准确的分子水平信息，辅助医生的精准治疗。至本医疗科技在上海创建 6 大自主知识产权平台的基因检测中心；拥有流程一体化等方面 6 项软件著作权专利的信息处理超算中心；国际标准的肿瘤精准研发中心；自主研发的"溯源至本"四大产品系列；业务网络覆盖全国五大区域；溯源至本，以静水流深的态度，开展癌症精准诊疗一体化的市场合作模式。至本医疗科技，"溯癌症之源，至诊疗之本"。专注—肿瘤精准医疗检测引领—国际领先行业标准践行—正直诚信道德准则提供—科学严谨检测服务The OrigiMed is a science and technology transforming company which focuses on developing new technologies and clinical translation for all cancer patients across China. By carrying out comprehensive detection via next generation high-throughput sequencing technologies, we provide personalized treatment options and consulting services for each individual cancer patient. We hold ourselves to a high-level of excellence, striving to create the maximum benefit for patients under the international standardization and quality control system.